Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39,309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients: First or third generation tyrosine kinase inhibitors (TKIs)?
Zhang B, Xu J, Zhang X, Gu P, Wang H, Wang S, Qian J, Qiao R, Zhang Y, Yang W, Qian F, Zhou Y, Lu J, Zhang L, Han B. Zhang B, et al. Among authors: zhang l, zhang x, zhang y. Lung Cancer. 2018 Mar;117:27-31. doi: 10.1016/j.lungcan.2018.01.006. Epub 2018 Jan 10. Lung Cancer. 2018. PMID: 29496252
OCT4&SOX2-specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem-like cells in vitro and treating drug-resistant lung cancer mice in vivo.
Zhang X, Hu F, Li C, Zheng X, Zhang B, Wang H, Tao G, Xu J, Zhang Y, Han B. Zhang X, et al. Among authors: zhang b, zhang y. J Cell Physiol. 2019 May;234(5):6758-6768. doi: 10.1002/jcp.27423. Epub 2018 Nov 1. J Cell Physiol. 2019. PMID: 30382588
39,309 results
You have reached the last available page of results. Please see the User Guide for more information.